Evidence map›Paper›PMID 33362767›Full record

ArticleFrontiers in immunology2020

Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality.

Jacqueline D Squire, Stephanie N Vazquez, Angela Chan, Michele E Smith, Deepak Chellapandian, Laura Vose, Beatriz Teppa, I Celine Hanson, Ivan K Chinn, Lisa Forbes-Satter and 12 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. How I Treat: Chronic granulomatous disease.Journal of human immunity · 2026
    Review
  5. The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel, Switzerland) · 2025
    Review
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

Jacqueline D SquireDivision of Allergy and Immunology, Department of Pediatrics, University of South Florida, St. Petersburg, FL, United States.
Stephanie N VazquezGraduate Medical Education, Memorial Healthcare System, Hollywood, FL, United States.
Angela ChanDivision of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Michele E SmithDivision of Critical Care Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Deepak ChellapandianBlood and Marrow Transplant, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
Laura VoseCritical Care Medicine, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
Beatriz TeppaCritical Care Medicine, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
I Celine HansonSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Ivan K ChinnSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Lisa Forbes-SatterSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Filiz O SeeborgSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Sarah K NicholasSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Caridad A MartinezDivision of Pediatric Hematology/Oncology, Texas Children's Hospital Cancer Center, Houston, TX, United States.
Carl E AllenDivision of Pediatric Hematology/Oncology, Texas Children's Hospital Cancer Center, Houston, TX, United States.
Thomas J ConnorsDivision of Critical Care Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Prakash SatwaniDivision of Hematology/Oncology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Maria ShtesselDivision of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Hanadys AleDivision of Allergy and Immunology, Joe DiMaggio Children's Hospital, Hollywood, FL, United States.
Lenora M NoroskiSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Nicholas L RiderSections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
Joshua D MilnerDivision of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
Jennifer W LeidingDivision of Allergy and Immunology, Department of Pediatrics, University of South Florida, St. Petersburg, FL, United States.
Columbia University Irving Medical Center · USTexas Children's Hospital · USBaylor College of Medicine · USJohns Hopkins All Children's Hospital · USUniversity of South Florida St. Petersburg · USJoe DiMaggio Children's Hospital · USJohns Hopkins University · USMemorial Healthcare System · US

Funding

ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
Development of Localized T Cell Immunity in Pediatric Respiratory Tract InfectionK23AI141686 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CONNORS, THOMAS · 2019 to 2023
$973k
NCI NIH HHS R01 CA154947NIAID NIH HHS K23 AI141686
6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) is a primary immune deficiency due to defects in phagocyte respiratory burst leading to severe and life-threatening infections. Patients with CGD also suffer from disorders of inflammation and immune dysregulation including colitis and granulomatous lung disease, among others. Additionally, patients with CGD may be at increased risk of systemic inflammatory disorders such as hemophagocytic lymphohistiocytosis (HLH). The presentation of HLH often overlaps with symptoms of systemic inflammatory response syndrome (SIRS) or sepsis and therefore can be difficult to identify, especially in patients with a primary immune deficiency in which incidence of infection is increased. Thorough evaluation and empiric treatment for bacterial and fungal infections is necessary as HLH in CGD is almost always secondary to infection. Simultaneous treatment of infection with anti-microbials and inflammation with immunosuppression may be needed to blunt the hyperinflammatory response in secondary HLH. Herein, we present a series of X-linked CGD patients who developed HLH secondary to or with concurrent disseminated CGD-related infection. In two patients, CGD was a known diagnosis prior to development of HLH and in the other two CGD was diagnosed as part of the evaluation for HLH. Concurrent infection and HLH were fatal in three; one case was successfully treated, ultimately receiving hematopoietic stem cell transplantation. The current literature on presentation, diagnosis, and treatment of HLH in CGD is reviewed.

Indexed as

AdolescentGranulomatous Disease, ChronicHematopoietic Stem Cell TransplantationHumansImmunosuppression TherapyInfantLymphohistiocytosis, HemophagocyticMaleSepsiscase reportchronic granulomatous diseasehemophagocytic lymphohistiocytosisinfectioninflammationprimary immune deficiencysepsis

Identifiers

PMID33362767
PMCPMC7756012
OpenAlexW3112956100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.